P-093 - A PHASE 1 STUDY OF SERPLULIMAB (A NOVEL ANTI-PD-1 ANTIBODY) IN COMBINATION WITH HLX04 (AN ANTI-VEGF ANTIBODY) IN PATIENTS WITH ADVANCED SOLID TUMORS.
Y. Guo1, J. Li1, Q. Li1, J. Xue1, L. Xue1, X. Ge1, F. Lin1, W. Zhao1, W. Tang1, D. Peng2, Q. Wang2, J. Zhu2; 1Shanghai East Hospital, Shanghai, China, 2Shanghai Henlius Biotech, Inc., Shanghai, China.
.jpg "Jin Li, MD, PhD photo")
.png)